Literature DB >> 1510395

Resistance to beta-lactams in Mycobacterium fortuitum.

L Fattorini1, G Orefici, S H Jin, G Scardaci, G Amicosante, N Franceschini, I Chopra.   

Abstract

It is widely assumed that the high level of intrinsic resistance to beta-lactam antibiotics exhibited by mycobacteria results from the combination of factors including permeability to the drugs, beta-lactamase production, and affinity for penicillin-binding proteins (PBPs). We conducted an evaluation of the second and third factors by isolating nitrosoguanidine-induced mutants from the beta-lactamase-producing strain Mycobacterium fortuitum ATCC 19542 that displayed either elevated or reduced resistance to various beta-lactam antibiotics. The mutants studied included D1 (a beta-lactamase producer with high penicillin resistance), gamma 27 (a low-level beta-lactamase producer with low penicillin resistance), and D316 (a high-level beta-lactamase producer with high penicillin resistance). In all strains examined, four major PBPs, named 1, 2a, 2b, and 3, with apparent molecular weights of 102,000, 90,000, 87,000, and 50,000, respectively, were found. The MICs of various beta-lactams toward ATCC 19542 and its mutants were considered in the context of beta-lactamase production, the quantity of PBPs synthesized, and their affinities for beta-lactam antibiotics. The data obtained show that beta-lactamase production is likely to be an important factor in the expression of resistance by clinical isolates and that PBP alterations can contribute to resistance at least in laboratory-derived mutants.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510395      PMCID: PMC188837          DOI: 10.1128/AAC.36.5.1068

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics.

Authors:  A Tomasz
Journal:  Rev Infect Dis       Date:  1986 Jul-Aug

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Maturation of the head of bacteriophage T4. I. DNA packaging events.

Authors:  U K Laemmli; M Favre
Journal:  J Mol Biol       Date:  1973-11-15       Impact factor: 5.469

4.  Inhibitors and inactivators of beta-lactamase from Mycobacterium fortuitum.

Authors:  L Fattorini; G Amicosante; D Fiorentino; N Franceschini; L Di Marzio; A Oratore; G Orefici
Journal:  J Chemother       Date:  1989-10       Impact factor: 1.714

5.  Characterization of a beta-lactamase produced in Mycobacterium fortuitum D316.

Authors:  G Amicosante; N Franceschini; B Segatore; A Oratore; L Fattorini; G Orefici; J Van Beeumen; J M Frere
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

6.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

7.  Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.

Authors:  L Fattorini; G Scardaci; S H Jin; G Amicosante; N Franceschini; A Oratore; G Orefici
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae.

Authors:  V Jarlier; L Gutmann; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

9.  Morphological changes induced by beta-lactam antibiotics in Mycobacterium avium-intracellulare complex.

Authors:  Y Mizuguchi; M Ogawa; T Udou
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

Authors:  R J Wallace; J M Swenson; V A Silcox; M G Bullen
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

View more
  12 in total

Review 1.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Altered permeability and beta-lactam resistance in a mutant of Mycobacterium smegmatis.

Authors:  S Mukhopadhyay; P Chakrabarti
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Biochemical characterization of the 49 kDa penicillin-binding protein of Mycobacterium smegmatis.

Authors:  T Mukherjee; D Basu; S Mahapatra; C Goffin; J van Beeumen; J Basu
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

5.  Crystal structure of the Mycobacterium fortuitum class A beta-lactamase: structural basis for broad substrate specificity.

Authors:  Eric Sauvage; Eveline Fonzé; Birgit Quinting; Moreno Galleni; Jean-Marie Frère; Paulette Charlier
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

6.  Identification and overexpression in Escherichia coli of a Mycobacterium leprae gene, pon1, encoding a high-molecular-mass class A penicillin-binding protein, PBP1.

Authors:  J Basu; S Mahapatra; M Kundu; S Mukhopadhyay; M Nguyen-Distèche; P Dubois; B Joris; J Van Beeumen; S T Cole; P Chakrabarti; J M Ghuysen
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

7.  Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds.

Authors:  M Galleni; N Franceschini; B Quinting; L Fattorini; G Orefici; A Oratore; J M Frère; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

8.  Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?

Authors:  H F Chambers; D Moreau; D Yajko; C Miick; C Wagner; C Hackbarth; S Kocagöz; E Rosenberg; W K Hadley; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

9.  Antigenic properties and immunoelectron microscopic localization of Mycobacterium fortuitum beta-lactamase.

Authors:  B Wagner; L Fattorini; M Wagner; S H Jin; R Stracke; G Amicosante; N Franceschini; G Orefici
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents.

Authors:  L J Utrup; T D Moore; P Actor; J A Poupard
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.